By G HossainPosted on August 28, 2026Posted in Pharmaceutical & Bio Science, UncategorizedTagged bio science career, blogs, business career news, career tips, job blog, job news, RJF Pharmaceutical Jobs Even without specific Phase 3 data yet revealed, analysts see AstraZeneca and Amgen’s Tezspire as a potential threat for Dupixent in eosinophilic esophagitis. AstraZeneca, Amgen poised to challenge Dupixent’s reign with esophagitis win Post navigation Multispecifics are transforming the CDMO development architectureGenentech strikes second Asia deal in a week, betting up to $1B in oncology ADC alliance with DualityBio